Almasry Pharmacy

Goutifade 40 Mg 30 Tablets

Short Description:
Goutifade 40 mg 30 tablets contains febuxostat, a xanthine oxidase inhibitor used to lower high uric acid levels and help prevent recurrent gout attacks. Taken once daily, it supports long-term control of hyperuricaemia and reduces urate crystal deposition in joints under medical supervision.

EGP 90

In Stock

delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG003264
BrandGoutifadeLink Icon
Categories
Medication & Treatments
Color
black
Concentrations
40 Mg
Shop by ConcernsGoutLink Icon, HyperuricemiaLink Icon, Joint PainLink Icon
Gender
Neutral
Shop By GoalsGout ManagementLink Icon, Joint ProtectionLink Icon, Lower Uric AcidLink Icon
Ingredient
Febuxostat
UPC
6223002144709
Product Form
Tablets
Specialty
Clinically Tested
Prescription only
Sub Categories
Gout Medicines
Unit Count
30 Tablets
Warning
Keep Out of Reach of Children
Caution In Liver Or Heart Disease
May Increase Gout Flares
Use under medical supervision only
About the product

Goutifade 40 Mg 30 Tablets

Description:

Goutifade 40 mg 30 tablets is a prescription oral medicine containing febuxostat, used to manage chronic hyperuricaemia (high uric acid levels) in adults, particularly in conditions where urate deposition has already occurred, such as gouty arthritis and tophi. It works by selectively inhibiting xanthine oxidase, the key enzyme responsible for uric acid production, thereby helping to reduce serum uric acid levels and prevent recurrent gout attacks and complications related to urate crystal deposition.


Indications:

  • Treatment of chronic hyperuricaemia in adults where urate deposition has already occurred (e.g., history of gouty arthritis, presence of tophi).
  • Prevention of recurrent gout attacks by maintaining lower serum uric acid levels.
  • Management of symptoms associated with gout such as joint pain, swelling, redness, and stiffness due to urate crystal deposition.
  • Long-term control of high uric acid levels to reduce the risk of further joint damage and urate-related complications.

Active Ingredients / Key Components:

  • Febuxostat – 40 mg per film-coated tablet.
  • Inactive ingredients (excipients) are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); full excipient list should be checked on the package insert or outer carton.

Dosage & Administration / How to Use:

  • Recommended adult dose: 1 tablet (40 mg) once daily, or as directed by the prescribing physician.
  • Can be taken with or without food; swallow the tablet whole with a sufficient amount of water.
  • Use at the same time each day to maintain stable uric acid control.
  • Do not stop taking Goutifade without consulting your doctor, even if gout symptoms improve, as uric acid levels may rise again.
  • Your doctor may adjust the dose based on serum uric acid levels, clinical response, and tolerability.
  • Not recommended for use in children and adolescents unless specifically prescribed by a specialist.
  • If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed dose.

Clinical Benefits:

  • Effectively lowers elevated serum uric acid levels by inhibiting xanthine oxidase, the enzyme responsible for uric acid formation.
  • Helps prevent recurrent gout attacks and reduces the frequency and severity of gout flares with regular use.
  • Supports long-term protection of joints and tissues by limiting urate crystal deposition and related inflammation.
  • Provides a once-daily oral regimen that can be taken with or without food, improving convenience and adherence to therapy.

Warnings & Contraindications:

  • Contraindicated in patients with known hypersensitivity to febuxostat or any of the excipients in the formulation.
  • Use with caution in patients with a history of major cardiovascular disease (e.g., myocardial infarction, stroke), as febuxostat has been associated with an increased risk of cardiovascular events in some studies; discuss risks and benefits with your doctor.
  • Use with caution in patients with liver impairment; liver function tests may be required before and during treatment.
  • Not recommended in patients receiving azathioprine, mercaptopurine, or theophylline unless under strict specialist supervision, due to potential serious interactions.
  • During the first weeks or months of treatment, gout attacks may temporarily increase as uric acid levels change; your doctor may prescribe additional medicines (e.g., NSAIDs or colchicine) to prevent or manage flares.
  • Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Use only if the potential benefit justifies the potential risk.
  • Consult your doctor before use if you have kidney disease, liver disease, heart disease, thyroid disorders, or are taking other prescription or over-the-counter medicines.
  • Do not exceed the prescribed dose or duration of treatment without medical advice.
  • Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription medication that must be used under a healthcare professional’s guidance.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include headache, mild nausea, diarrhea, abdominal pain, joint pain, and rash.
  • Gout flares may occur, especially at the start of treatment, as uric acid levels are being reduced.
  • Less common but potentially serious side effects can include severe skin reactions, allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing), liver function abnormalities, and cardiovascular events (chest pain, shortness of breath, sudden weakness or numbness).
  • Stop taking the medicine and seek immediate medical attention if you experience signs of a severe allergic reaction, severe skin rash, yellowing of the skin or eyes, dark urine, unexplained chest pain, sudden shortness of breath, or any other worrying symptoms.
  • Report any persistent or bothersome side effects to your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at or below the temperature specified on the outer carton or leaflet (exact temperature range not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); refer to the product pack).


Specifications:
  • Product type: Prescription medicine for gout and hyperuricaemia.
  • Strength: 40 mg febuxostat per film-coated tablet.
  • Form: Film-coated tablet.
  • Pack size: 30 tablets per pack.
  • Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

More fromGoutifade

See More

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp